Stay updated on Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.5, replacing the prior v3.6.4, indicating a small platform/template update.
    Difference
    0.1%
    Check dated 2026-08-10T15:30:50.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, indicating a minor update to the page or its underlying components reflected in the revision history.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:23.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    No additions or deletions were provided. The page content about the study details remains unchanged.
    Difference
    0.1%
    Check dated 2026-07-12T22:38:43.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.2 to v3.6.3, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-07-05T13:58:00.000Z thumbnail image
  8. Check
    63 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.0 to v3.6.2, indicating a maintenance update to the ClinicalTrials.gov record. This reflects behind-the-scenes fixes or tweaks and does not alter the study details presented to users.
    Difference
    0.1%
    Check dated 2026-06-28T08:37:35.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    The study record now indicates termination due to poor accrual and includes the note 'No longer looking for participants.' Navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study), and the revision label was updated to v3.6.0 with a heading adjustment for Intervention/Treatment.
    Difference
    0.6%
    Check dated 2026-06-13T17:32:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.